TNFRSF12A and amyotrophic lateral sclerosis: Of note is that in both TWEAK- and Fn14-depleted SOD1G93A ALS mice, there were no significant improvements in motor function [33], suggesting that simply targeting the TWEAK/Fn14 pathway is not sufficient for the recovery of the neuromuscular unit.